Free Trial

Silexion Therapeutics Corp - Warrant (SLXNW) 10K Form and Latest SEC Filings 2026

$0.01 0.00 (-20.75%)
Closing price 01:52 PM Eastern
Extended Trading
$0.01 +0.00 (+7.94%)
As of 04:01 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Latest Silexion Therapeutics Corp - Warrant SEC Filings & Recent Activity

Silexion Therapeutics Corp - Warrant (NASDAQ:SLXNW) has submitted 166+ documents to the U.S. Securities and Exchange Commission (SEC) since 2024. For investors, these filings are the primary source of verified financial data — covering everything from annual revenue and debt levels in the 10-K, to material business events in 8-K current reports, to insider buying and selling activity in Form 4 disclosures. The most recent filing was a Form 8-K submitted on May 5, 2026.

Form 4
Silexion Therapeutics Corp Reports Ownership Change on Feb. 23, 2026

Form 4 filings disclose changes in stock ownership by company insiders, including purchases, sales, grants, and option exercises.

View insider ownership

8-K
Silexion Therapeutics Corp - Warrant Files Current Report on May. 5, 2026

An 8-K is filed when a material corporate event occurs, such as an acquisition, leadership change, or financial update.

View filing

10-Q
Silexion Therapeutics Corp - Warrant Files Quarterly Report on Nov. 12, 2025

The 10-Q contains Silexion Therapeutics Corp - Warrant's unaudited quarterly financial statements, revenue, earnings updates, and cash flow changes between annual reports.

View earnings history

Silexion Therapeutics Corp - Warrant SEC Filing History

Browse Silexion Therapeutics Corp - Warrant's complete SEC filing history using the filters below. Filter by form type - 10-K, 10-Q, 8-K, Form 4, and more - or set a custom date range to find a filing.

DateFilerForm TypeView
05/05/2026 3:06 PM
Silexion Therapeutics Corp - Warrant (2022416) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/28/2026 3:05 PM
Silexion Therapeutics Corp - Warrant (2022416) Filer
Form DEFA14A
04/28/2026 7:58 AM
Silexion Therapeutics Corp - Warrant (2022416) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/09/2026 3:26 PM
Silexion Therapeutics Corp - Warrant (2022416) Filer
Form DEF 14A
03/31/2026 10:17 AM
Silexion Therapeutics Corp - Warrant (2022416) Filer
Form PRE 14A
03/25/2026 3:05 PM
Silexion Therapeutics Corp - Warrant (2022416) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/24/2026 8:08 AM
Silexion Therapeutics Corp - Warrant (2022416) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/23/2026 3:32 PM
Silexion Therapeutics Corp - Warrant (2022416) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/16/2026 3:05 PM
Silexion Therapeutics Corp - Warrant (2022416) Filer
Form DEFA14A
02/23/2026 3:18 PM
Shirvan Mitchell (1727789) Reporting
Silexion Therapeutics Corp - Warrant (2022416) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
02/23/2026 3:20 PM
Alon Ruth (1796386) Reporting
Silexion Therapeutics Corp - Warrant (2022416) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
02/23/2026 3:11 PM
Peled Amnon (2048879) Reporting
Silexion Therapeutics Corp - Warrant (2022416) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
02/23/2026 3:13 PM
Abramov Dror Yosef (2034083) Reporting
Silexion Therapeutics Corp - Warrant (2022416) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
02/13/2026 3:49 PM
INTRACOASTAL CAPITAL, LLC (1646799) Filed by
Silexion Therapeutics Corp - Warrant (2022416) Subject
Form SCHEDULE 13G/A
02/13/2026 3:09 PM
Silexion Therapeutics Corp - Warrant (2022416) Filer
Form PRE 14A
02/03/2026 8:50 AM
Silexion Therapeutics Corp - Warrant (2022416) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/27/2026 10:03 AM
Levin Ilan (1849189) Reporting
Moringa Sponsor, LP (1849192) Reporting
Silexion Therapeutics Corp - Warrant (2022416) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
01/06/2026 7:24 AM
Silexion Therapeutics Corp - Warrant (2022416) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/31/2025 12:00 PM
Peled Amnon (2048879) Reporting
Silexion Therapeutics Corp - Warrant (2022416) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
12/31/2025 12:04 PM
Lushi Avner (2033604) Reporting
Silexion Therapeutics Corp - Warrant (2022416) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
12/31/2025 12:07 PM
Noy Shlomo (2033211) Reporting
Silexion Therapeutics Corp - Warrant (2022416) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
12/31/2025 12:09 PM
Alon Ruth (1796386) Reporting
Silexion Therapeutics Corp - Warrant (2022416) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
12/31/2025 12:13 PM
Abramov Dror Yosef (2034083) Reporting
Silexion Therapeutics Corp - Warrant (2022416) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
12/16/2025 7:48 AM
Silexion Therapeutics Corp - Warrant (2022416) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/02/2025 7:33 AM
Silexion Therapeutics Corp - Warrant (2022416) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/25/2025 8:25 AM
Silexion Therapeutics Corp - Warrant (2022416) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/12/2025 8:01 AM
Silexion Therapeutics Corp - Warrant (2022416) Filer
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/12/2025 8:07 AM
Silexion Therapeutics Corp - Warrant (2022416) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/31/2025 4:06 PM
Silexion Therapeutics Corp - Warrant (2022416) Filer
Form S-3
Registration statement under Securities Act of 1933  
09/30/2025 11:15 PM
Silexion Therapeutics Corp - Warrant (2022416) Filer
Form EFFECT
09/30/2025 8:05 AM
Silexion Therapeutics Corp - Warrant (2022416) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/26/2025 3:30 PM
Silexion Therapeutics Corp - Warrant (2022416) Filer
Form S-3
Registration statement under Securities Act of 1933  
09/26/2025 3:05 PM
Silexion Therapeutics Corp - Warrant (2022416) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/25/2025 7:00 AM
Silexion Therapeutics Corp - Warrant (2022416) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/23/2025 10:17 AM
Moringa Sponsor, LP (1849192) Filed by
Silexion Therapeutics Corp - Warrant (2022416) Subject
Form SCHEDULE 13D/A
09/18/2025 4:47 PM
Lind Global Fund III LP (2071860) Filed by
Silexion Therapeutics Corp - Warrant (2022416) Subject
Form SCHEDULE 13G
09/17/2025 4:14 PM
INTRACOASTAL CAPITAL, LLC (1646799) Filed by
Silexion Therapeutics Corp - Warrant (2022416) Subject
Form SCHEDULE 13G
09/15/2025 4:19 PM
Orca Capital AG (2052389) Filed by
Silexion Therapeutics Corp - Warrant (2022416) Subject
Form SCHEDULE 13G
09/15/2025 4:23 PM
Orca Capital AG (2052389) Filed by
Silexion Therapeutics Corp - Warrant (2022416) Subject
Form SCHEDULE 13G/A
09/15/2025 3:35 PM
Silexion Therapeutics Corp - Warrant (2022416) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/15/2025 11:31 AM
Lincoln Alternative Strategies LLC (2043812) Filed by
Silexion Therapeutics Corp - Warrant (2022416) Subject
Form SCHEDULE 13G
09/12/2025 3:30 PM
Silexion Therapeutics Corp - Warrant (2022416) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/12/2025 7:33 AM
Silexion Therapeutics Corp - Warrant (2022416) Filer
Form 424B4
09/11/2025 11:15 PM
Silexion Therapeutics Corp - Warrant (2022416) Filer
Form EFFECT
09/11/2025 6:31 AM
Silexion Therapeutics Corp - Warrant (2022416) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/05/2025 3:17 PM
Silexion Therapeutics Corp - Warrant (2022416) Filer
Form S-1
Registration statement under Securities Act of 1933  
09/04/2025 11:15 PM
Silexion Therapeutics Corp - Warrant (2022416) Filer
Form EFFECT
09/04/2025 4:29 PM
Silexion Therapeutics Corp - Warrant (2022416) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/04/2025 8:30 AM
Silexion Therapeutics Corp - Warrant (2022416) Filer
Form 424B3
09/02/2025 7:31 AM
Silexion Therapeutics Corp - Warrant (2022416) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/26/2025 3:08 PM
Silexion Therapeutics Corp - Warrant (2022416) Filer
Form S-1
Registration statement under Securities Act of 1933  
08/20/2025 4:17 PM
Silexion Therapeutics Corp - Warrant (2022416) Filer
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
08/19/2025 9:05 AM
Silexion Therapeutics Corp - Warrant (2022416) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/12/2025 3:14 PM
Silexion Therapeutics Corp - Warrant (2022416) Filer
Form 424B3
08/12/2025 3:16 PM
Silexion Therapeutics Corp - Warrant (2022416) Filer
Form 424B3
08/12/2025 3:19 PM
Silexion Therapeutics Corp - Warrant (2022416) Filer
Form 424B3
08/12/2025 9:31 AM
Silexion Therapeutics Corp - Warrant (2022416) Filer
Form DEFA14A
08/12/2025 7:31 AM
Silexion Therapeutics Corp - Warrant (2022416) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/11/2025 5:02 AM
Silexion Therapeutics Corp - Warrant (2022416) Filer
Form D
Notice of Exempt Offering of Securities 
08/01/2025 11:23 AM
Silexion Therapeutics Corp - Warrant (2022416) Filer
Form 424B3
08/01/2025 11:23 AM
Silexion Therapeutics Corp - Warrant (2022416) Filer
Form 424B3
08/01/2025 11:29 AM
Silexion Therapeutics Corp - Warrant (2022416) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/31/2025 11:17 AM
Silexion Therapeutics Corp - Warrant (2022416) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/31/2025 8:13 AM
Silexion Therapeutics Corp - Warrant (2022416) Filer
Form DEF 14A
07/29/2025 8:10 AM
Silexion Therapeutics Corp - Warrant (2022416) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/21/2025 11:05 AM
Silexion Therapeutics Corp - Warrant (2022416) Filer
Form PRE 14A
07/16/2025 7:55 AM
Silexion Therapeutics Corp - Warrant (2022416) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/14/2025 3:05 PM
Silexion Therapeutics Corp - Warrant (2022416) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/09/2025 8:15 AM
Silexion Therapeutics Corp - Warrant (2022416) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/08/2025 3:05 PM
Silexion Therapeutics Corp - Warrant (2022416) Filer
Form 8-K/A
07/08/2025 8:35 AM
Silexion Therapeutics Corp - Warrant (2022416) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/07/2025 8:29 AM
Silexion Therapeutics Corp - Warrant (2022416) Filer
Form DEFA14A
06/26/2025 3:15 PM
Silexion Therapeutics Corp - Warrant (2022416) Subject
Wildcat Capital Management, LLC (1582384) Filed by
Form SCHEDULE 13D/A
06/23/2025 3:48 PM
Silexion Therapeutics Corp - Warrant (2022416) Filer
Form DEFA14A
06/16/2025 9:51 AM
Silexion Therapeutics Corp - Warrant (2022416) Filer
Form DEF 14A
05/29/2025 11:15 PM
Silexion Therapeutics Corp - Warrant (2022416) Filer
Form EFFECT
05/29/2025 9:14 AM
Silexion Therapeutics Corp - Warrant (2022416) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/28/2025 3:04 PM
Silexion Therapeutics Corp - Warrant (2022416) Filer
Form POS AM
05/23/2025 4:00 PM
Silexion Therapeutics Corp - Warrant (2022416) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/21/2025 8:20 AM
Silexion Therapeutics Corp - Warrant (2022416) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/13/2025 4:01 PM
Silexion Therapeutics Corp - Warrant (2022416) Filer
Form 424B3
05/13/2025 10:36 AM
GOLDMAN SACHS GROUP INC (886982) Filed by
Silexion Therapeutics Corp - Warrant (2022416) Subject
Form SCHEDULE 13G/A
05/12/2025 11:12 AM
CVI Investments, Inc. (1649553) Filed by
Silexion Therapeutics Corp - Warrant (2022416) Subject
Form SCHEDULE 13G/A
05/06/2025 7:35 AM
Silexion Therapeutics Corp - Warrant (2022416) Filer
Form 424B3
(Data available from 1/1/2016 forward)

Silexion Therapeutics Corp - Warrant SEC Filings - Frequently Asked Questions

Silexion Therapeutics Corp - Warrant (SLXNW) has submitted 166+ filings to the SEC since 2024. You can browse the complete history or filter by form type using the tools above.

The most recent filing was a Form 8-K submitted on May 5, 2026. This was a current report on a material business event.

SEC Filing Types: 10-K, 10-Q, 8-K and More

SEC filings are legally required disclosures that public companies submit to the U.S. Securities and Exchange Commission. Unlike press releases or earnings call transcripts, these documents are filed under legal obligation — meaning the financial data they contain is audited, standardized, and subject to penalties if materially false. For investors, that makes SEC filings the most reliable primary source available for evaluating a company's true financial position.

Yes. All SEC filings are publicly available through the SEC's EDGAR database and on financial research platforms like MarketBeat. Companies are required by law to make these disclosures accessible to all investors — meaning retail investors have access to the same source documents as institutional analysts.

A 10-K is an annual report containing audited financial statements and a full review of the company's business — it is the most comprehensive filing a company makes each year. A 10-Q is a shorter, unaudited quarterly update filed three times per year between annual reports. Investors typically use the 10-K for deep fundamental analysis and the 10-Q to track whether the company is on pace with its guidance mid-year.

The most important filing for fundamental investors. Filed once per year, the 10-K contains audited financial statements, revenue and earnings trends, debt obligations, risk factors, and management's own assessment of the business. Reading the risk factors section and comparing year-over-year financials can reveal issues that don't show up in analyst summaries.

An unaudited financial update filed three times per year (the 10-K covers Q4). Investors use 10-Qs to track whether guidance is on pace, monitor changes in cash flow or inventory, and catch any mid-year shifts in business conditions before they become headline news.

Filed within four business days of a material event — earnings releases, merger announcements, executive departures, or major asset sales. Because 8-Ks are filed before media coverage catches up, they are often the fastest way to get unfiltered information directly from the company on market-moving events.

Filed within two business days whenever an executive or director buys or sells company stock. Insider purchases — especially large or clustered buys — are often interpreted as a signal of management confidence. Insider selling is more ambiguous but worth monitoring for patterns, particularly around lock-up expirations or ahead of major announcements.


Related Companies and Tools


This page (NASDAQ:SLXNW) was last updated on 5/5/2026 by MarketBeat.com Staff.
From Our Partners